Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population

Hypertension

Volumn 34, Issue 3, 1999, Pages 423-429

  Paillard, Françoise ^a   Chansel, Dominique ^a   Brand, Eva ^b   Benetos, Athanase ^c   Thomas, Frédérique ^d   Czekalski, Stanislaw ^a   Ardaillou, Raymond ^a   Soubrier, Florent ^b  

^a HÔPITAL TENON   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSERM   (France)

^d Centre Investigations Preventives et Cliniques   (France)

Author keywords

Aldosterone; Angiotensin II; Angiotensin converting enzyme; Angiotensinogen; Blood pressure; Polymorphism

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ANGIOTENSIN BLOOD LEVEL; ARTICLE; BLOOD PRESSURE REGULATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0032886569     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.3.423     Document Type: Article

References (30)

1. Villard E, Soubrier F. Molecular biology and genetics of the angiotensin I-converting enzyme: potential implications in cardiovascular diseases. Cardiovasc Res. 1996;32:999-1007.
2. Kehoe PG, Russ C, McIlory S, Williams H, Holmans P, Holmes C, Liolitsa D, Vahidassr D, Powell J, McGleenon B, Liddell M, Plomin R, Dynan K, Williams N, Neal J, Cairns NJ, Wilcock G, Passmore P, Lovestone S, Williams J, Owen MJ. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat Genet. 1999; 21:71-72.
3. Jeunemaitre X, Soubrier F, Kotelevtsev Y, Lifton R, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71: 169-180.
4. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
5. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension. 1997;29:1078-1082.
6. Pham-Huu-Trung MT, Corvol P. A direct determination of plasma aldosterone. Steroids. 1974;24:587-608.
7. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension 1985;7(suppl I):I-1-I-7.
8. Budisavljevic M, Geniteau-Legendre M, Baudouin B, Pontillon F, Verroust PJ, Ronco PM. Angiotensin II (AII)-related idiotypic network, II: heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies. J Immunol. 1988;140:3059-3065.
9. Simon D, Hartmann DJ, Badouaille G, Caillot G, Guyenne TT, Corvol P, Pau B, Marchand J. Two-site direct immunoassay specific for active renin. Clin Chem. 1992;38:1959-1962.
10. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979;95: 540-548.
11. Ménard J, Catt KJ. Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin II. Endocrinology. 1972;90:422-430.
12. 125I-Angiotensin II binding to human blood cells. J Hypertens. 1985;3:131-137.
13. Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980;107: 220-239.
14. Marcadet A, O'Connell P, Cohen D. Standardized Southern blot workshop technique. Histocompatibility Testing. 1986;I:553-I560.
15. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F. Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am J Hum Genet. 1996;58:1268-1278.
16. Saiki RK, Bugawan TL, Horn GT, Mullis KB, Erlich HA. Analysis of enzymatically amplified β-globin and HLA-DQ α DNA with allele-specific oligonucleotide probes. Nature. 1986;324:163-166.
17. Brand E, Chatelain N, Mulatero P, Fery I, Curnow K, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in human hypertension. Hypertension. 1998;32:198-204.
18. Moore TJ, Taylor T, Williams GH. Human platelet angiotensin II receptors: regulation by the circulating angiotensin level. J Clin Endocrinol Metab. 1984;58:778-782.
19. Makarious M, Pawlak M, Campbell LV, Timmermans V, Duggan K, Charlesworth JA, Macdonald GJ. The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathy. Eur J Clin Invest. 1993;23:517-521.
20. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
21. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
22. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau V. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res. 1993;72:312-318.
23. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, Larosa E, Guize L, Safar M, Soubrier F, Cambien F. Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation. 1996;94:698-703.
24. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol. 1999;10(suppl 11):S30-S39.
25. Duggan J, Kilfeather S, O'Brien E, O'Malley K, Nussberger J. Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density. Am J Hypertens. 1992;5:687-693
26. Hautanen A, Lankinen L, Kupari M, Janne OA, Adlercreutz H, Nikkila H, White PC. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med. 1998;244:11-18.
27. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JM. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999;33:703-707.
28. Pojoga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens. 1998;11:856-860.
29. White PC, Slutsker L. Haplotype analysis of CYP11B2. Endocr Res. 1995;21:437-442.
30. Clyne CD, Zhang Y, Slutsker L, Mathis JM, White PC, Rainey WE. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol. 1997;11:638-649.